MCO

Subscribe to Selected New Research on MCO

71 relevant articles (3 outcomes, 19 trials/studies) found for this Bio-Agent

Description: structure

Also Known As:

(6R,7R)-7-((2R)-2-hydroxy-2-phenylacetamido)-3-(pyrid-2-yl-N-oxide)thiomethylceph-3-em 4-carboxylic acid; (6R-(6 alpha,7 beta(R)))-7-((hydroxyphenylacetyl)amino)-8-oxo-3-((2-pyridinylthio) methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid monooxide

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Polycyclic Compounds: 58

Bridged Compounds: 2

Bicyclo Compounds

Heterocyclic Bicyclo Compounds

Experts

1.	Woodward, Billy: 1 article (03/2003)
2.	Godley, Paul: 1 article (03/2003)
3.	Nguyen, Anh: 1 article (03/2003)
4.	Chiang, Tina: 1 article (03/2003)
5.	Yokoyama, Krista: 1 article (03/2003)
6.	Rohack, James: 1 article (03/2003)
7.	O'Connell, John B: 1 article (05/2002)
8.	de Lissovoy, Gregory: 1 article (05/2002)
9.	Zodet, Marc: 1 article (05/2002)
10.	Coyne, Karen: 1 article (05/2002)

Related Diseases

1.	Wounds and Injuries (Trauma) 07/01/2002 - "BACKGROUND: Efforts to control injuries within managed care organization (MCO) populations require information about the incidence and costs associated with the injuries cared for in MCOs" 04/01/2001 - "Changes in the Medicare reimbursement system for home health care may have provided an equalizing effect between Medicare MCO and traditional Medicare patients with wound/skin diagnoses in home health care agencies in the Midwest." 08/01/2002 - "The concurrent data collection processes used in the MCO program for performance measurement of resuscitation efforts, intubations, submersion incidents and aeromedical transports for trauma cases have been very effective in the integration of data from multiple computer databases and telephone follow-ups with field crews and receiving emergency department staffs" 07/01/2002 - "OBJECTIVE: This study uses administrative data to measure the rates and the costs of burn, choking, poisoning, blunt, and penetrating injuries in an urban Medicaid MCO" Get all the results and reference details, order at left...
2.	Breast Neoplasms (Breast Cancer) 07/01/1997 - "Slashing breast cancer screening costs and improving outcomes: Implementing an innovative multidisciplinary approach to diagnosing breast cancer and narrowing its team to dedicated "breast specialists" has helped this community hospital's breast center win more MCO contracts--despite its location in the shadow of a world-renowned center" 11/01/2008 - "These themes, and their accompanying categories, depict the increased burden encountered by women experiencing breast cancer in a managed care system who perceived that they were solely responsible for mediating between their care providers and MCO" 02/01/2005 - "OBJECTIVES: An evaluation was performed linking an administrative database to clinical information to determine the clinical and economic outcomes of women presenting with breast cancer in a managed care organization (MCO)" 11/01/2008 - "In this study, we used a hermeneutic phenomenological approach involving semistructured interviews of 14 women with breast cancer to examine MCO enrollees' experiences related to their cancer treatment" Get all the results and reference details, order at left...
3.	Motion Sickness (Airsickness) 10/05/1950 - "Amidryl MCO, an effective remedy in seasickness.]" Get all the results and reference details, order at left...
4.	Epilepsy (Aura) 02/01/2005 - "A data set of potential epilepsy cases was constructed from an MCO's administrative data system for all health plan members continuously enrolled in the MCO for at least 1 year within the study period of July 1, 1996 through June 30, 1998" 02/01/2005 - "PURPOSE: The purpose of the present study was to apply computer algorithms to an administrative data set to identify the prevalence of epilepsy, incidence of epilepsy, and epilepsy-related mortality of patients in a managed care organization (MCO)" 06/01/2008 - "The modular and efficient design of the MCO should facilitate the process of implementing coupled MCO networks in electronic hardware as potential neural prostheses for treating dynamic diseases such as epilepsy." Get all the results and reference details, order at left...
5.	Dyspepsia (Indigestion) 08/01/1997 - "METHODS: Two hundred and twenty-six patients with functional dyspepsia were included in a double-blind multi-crossover (MCO) trial" 07/01/1991 - "One hundred and fifteen patients with non-ulcer dyspepsia from seven Norwegian hospitals were included in a 6-week double-blind MCO-designed trial with alternating weekly treatments with ranitidine and placebo" 01/01/1985 - "The symptomatic effect of cimetidine was examined in 27 patients with non-ulcer dyspepsia (NUD) by means of a multi-cross-over model (MCO model) for testing the symptomatic effect of drugs in individual patients" Get all the results and reference details, order at left...
68 Diseases and 71 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	5-HT1 Serotonin Receptors
2.	Tryptamines (Triptans)
3.	Ranitidine (Zantac)
4.	Dihydroergotamine (Agit)
5.	Carbon Monoxide
6.	sildenafil (Viagra)
7.	Hydroxyl Radical
8.	Reactive Oxygen Species (Oxygen Radicals)
9.	Free Radicals
10.	Copper
27 Drugs and Important Bio-Agents and 17 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Resuscitation
2.	Prostheses and Implants (Prosthesis)
3.	Transplantation (Transplant Recipients)
4.	Osteotomy
5.	Drug Therapy (Chemotherapy)
7 Therapies and Procedures and 6 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>